Liberty Street Advisors’s Virtus Biotech Clinical Trials ETF BBC Stock Holding History

Liberty Street Advisors’s Portfolio BBC Stock Details BBC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	$204K	Buy	+7,039	New	+$203K	4.94%	8

Other funds holding BBC

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

LTFS

Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Liberty Street Advisors's BBC Position: Q4 2015 in Review

Liberty Street Advisors opened a new position in Virtus Biotech Clinical Trials ETF (BBC) in Q4 2015: 7,039 shares worth $204K. The stake represents 4.94% of the portfolio and ranks #8 among its holdings.

17 funds tracked by Wall St. Rank hold BBC as of Q4 2015.

Liberty Street Advisors held 7,039 shares of Virtus Biotech Clinical Trials ETF worth $204K as of Q4 2015.
Virtus Biotech Clinical Trials ETF was a new Liberty Street Advisors position in Q4 2015.
Virtus Biotech Clinical Trials ETF made up 4.94% of Liberty Street Advisors's portfolio in Q4 2015, its #8 holding.
17 funds tracked by Wall St. Rank held Virtus Biotech Clinical Trials ETF as of Q4 2015.

Based on Liberty Street Advisors's 13F filing for Q4 2015, filed 8 Feb 2016.